Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

G Ploussard; H Isbarn; A Briganti; P Sooriakumaran; CI Surcel; L Salomon; M Freschi; C Mirvald; HG van der Poel; A Jenkins; P Ost; IM van Oort; O Yossepowitch; G Giannarini; RCN Bergh

doi:10.1016/j.urolonc.2014.07.007

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

G Ploussard, H Isbarn, A Briganti, P Sooriakumaran, CI Surcel, L Salomon, M Freschi, C Mirvald, HG van der Poel, A Jenkins, P Ost, IM van Oort, O Yossepowitch, G Giannarini, RCN Bergh

Urology

Research output: Contribution to journal › Article › Academic

71 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1-9
Number of pages	9
Journal	Urology Oncology
Volume	33
Issue number	2
DOIs	https://doi.org/10.1016/j.urolonc.2014.07.007
Publication status	Published - 2015

Research programs

EMC MM-03-49-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urolonc.2014.07.007

Cite this

Ploussard, G., Isbarn, H., Briganti, A., Sooriakumaran, P., Surcel, CI., Salomon, L., Freschi, M., Mirvald, C., van der Poel, HG., Jenkins, A., Ost, P., van Oort, IM., Yossepowitch, O., Giannarini, G., & Bergh, RCN. (2015). Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients. Urology Oncology, 33(2), 1-9. https://doi.org/10.1016/j.urolonc.2014.07.007

@article{f8816e255ed14c909d4757bd17d17cb9,

title = "Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients",

author = "G Ploussard and H Isbarn and A Briganti and P Sooriakumaran and CI Surcel and L Salomon and M Freschi and C Mirvald and \{van der Poel\}, HG and A Jenkins and P Ost and \{van Oort\}, IM and O Yossepowitch and G Giannarini and RCN Bergh",

year = "2015",

doi = "10.1016/j.urolonc.2014.07.007",

language = "Undefined/Unknown",

volume = "33",

pages = "1--9",

number = "2",

}

Ploussard, G, Isbarn, H, Briganti, A, Sooriakumaran, P, Surcel, CI, Salomon, L, Freschi, M, Mirvald, C, van der Poel, HG, Jenkins, A, Ost, P, van Oort, IM, Yossepowitch, O, Giannarini, G & Bergh, RCN 2015, 'Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients', Urology Oncology, vol. 33, no. 2, pp. 1-9. https://doi.org/10.1016/j.urolonc.2014.07.007

TY - JOUR

T1 - Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

AU - Ploussard, G

AU - Isbarn, H

AU - Briganti, A

AU - Sooriakumaran, P

AU - Surcel, CI

AU - Salomon, L

AU - Freschi, M

AU - Mirvald, C

AU - van der Poel, HG

AU - Jenkins, A

AU - Ost, P

AU - van Oort, IM

AU - Yossepowitch, O

AU - Giannarini, G

AU - Bergh, RCN

PY - 2015

Y1 - 2015

U2 - 10.1016/j.urolonc.2014.07.007

DO - 10.1016/j.urolonc.2014.07.007

M3 - Article

C2 - 25131660

VL - 33

SP - 1

EP - 9

JO - Urology Oncology

JF - Urology Oncology

IS - 2

ER -